Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Artificially aminoacylated suppressor tRNAs were used to introduce photoreactive amino acids into model mitochondrial precursor proteins to probe the environment along the protein import pathway. Amino acids with benzophenone side chains of various lengths [DL-2-amino-3-(p-benzoylphenyl)propanoic acid (1) and DL-2-amino-5-(p-benzoylphenyl)
pentanoic acid
(2)] were incorporated at specific sites throughout the cytochrome b2-
dihydrofolate reductase
fusion proteins, pb2(220)-
DHFR
and pb2 delta 19(220)-
DHFR
, which were destined for the intermembrane space and the matrix in mitochondria, respectively. In vitro import of pb2(220)-
DHFR
and pb2 delta 19(220)-
DHFR
bearing 1 or 2 into isolated yeast mitochondria was arrested so that the N terminus reached the intermembrane space or the matrix, respectively, while the
DHFR
domain remained at the mitochondrial surface. The matrix-targeted pb2 delta 19(220)-
DHFR
was photocrosslinked to Tom40 in the outer membrane, Tim44 in the inner membrane, and Ssc1p in the matrix, suggesting that the protein has an extended conformation in the import channels. On the other hand, incorporation of 2 at various positions in the 50-residue segment of intermembrane-space-targeted pb2(220)-
DHFR
gave photocrosslinks only to Tom40, suggesting that the segment is not in an extended conformation, but localized near Tom40. The N-terminal portion of pb2(220)-
DHFR
, but not pb2 delta 19(220)-
DHFR
, was photocrosslinked to an as-yet-unidentified mitochondrial component to generate a 95-kDa crosslinked product.
...
PMID:Probing the environment along the protein import pathways in yeast mitochondria by site-specific photocrosslinking. 901 10
Two fluorinated derivatives of isoleucine: d,l-2-amino-3-trifluoromethyl
pentanoic acid
(3TFI, 2) and d,l-2-amino-5,5,5-trifluoro-3-methyl
pentanoic acid
(5TFI, 3) were prepared. 5TFI was incorporated into a model target protein, murine
dihydrofolate reductase
(mDHFR), in an isoleucine auxotrophic Escherichia coli host strain suspended in 5TFI-supplemented minimal medium depleted of isoleucine. Incorporation of 5TFI was confirmed by tryptic peptide analysis and matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) of the protein product. Amino acid analysis showed that more than 93% of the encoded isoleucine residues were replaced by 5TFI. Measurement of the rate of activation of 5TFI by the E. coli isoleucyl-tRNA synthetase (IleRS) yielded a specificity constant (k(cat)/K(m)) 134-fold lower than that for isoleucine. 5TFI was successfully introduced into the cytokine murine interleukin-2 (mIL-2) at the encoded isoleucine positions. The concentration of fluorinated protein that elicits 50% of the maximal proliferative response is 3.87 ng/mL, about 30% higher than that of wild-type mIL-2 (EC(50) = 2.70 ng/mL). The maximal responses are equivalent for the fluorinated and wild-type cytokines, indicating that fluorinated proteins can fold into stable and functional structures. 3TFI yielded no evidence for in vivo incorporation into recombinant proteins, and no evidence for activation by IleRS in vitro.
...
PMID:Incorporation of trifluoroisoleucine into proteins in vivo. 1278 42